ITC (ITC)
LARGE CAPFairStock Score: 78/100 — SPECULATIVE
Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 1/1
Key Financials
| Current Price | ₹305.3 |
| Market Cap | ₹3,92,916.63 Cr |
| P/E Ratio | 19.05 |
| ROCE | 36.79% |
| ROE | 49.75% |
| Dividend Yield | 4.58% |
| Profit Growth | 73.02% |
| Debt/Equity | 0.01 |
| Sales Growth | 8.44% |
| Free Cash Flow | ₹17,06,300 Cr |
| Promoter Holding | 0% |
| 52-Week Range | ₹275 — ₹427.2 |
| Sector | Diversified FMCG |
| Book Value | ₹56.72 |
Investment Thesis
ITC is a cash-generating behemoth with world-class capital efficiency, offering investors a rare combination of a reasonable valuation, high dividend yield, and improving profitability across its diversified business segments. While the tobacco business remains the profit engine, the FMCG and hotels segments are gradually maturing into meaningful contributors. At Rs 305, the stock offers a comfortable margin of safety for income-seeking and long-term investors.
Rating: BUY (MEDIUM confidence) — 24M horizon
Strengths
- Exceptional capital efficiency with a ROCE of 36.79%, one of the highest among Indian large-cap diversified companies, reflecting the tobacco segment's extraordinary profitability and disciplined capital allocation.
- Attractive dividend yield of 4.58% makes ITC a compelling income stock, particularly in a market where high-quality yield above 4% is rare among large-cap names — ideal for conservative and retired investors.
- Dominant and near-unassailable market position in the Indian cigarette industry, backed by a pan-India distribution network of over 6 million retail outlets that also supports its FMCG growth ambitions.
Concerns
- Structural long-term decline in tobacco consumption driven by health awareness, regulatory action, and demographic shifts poses an existential challenge to ITC's primary profit engine over the next decade.
- FMCG segment profitability remains suboptimal despite over 15 years of investment, raising questions about competitive positioning against entrenched players like HUL, Britannia, and Dabur in key categories.
- Modest sales growth of 8.44% suggests limited top-line momentum, and if tobacco volumes continue to decline, revenue growth could decelerate further unless non-tobacco segments scale up meaningfully and quickly.
AI Analysis
Here is what you need to know about ITC. This is one of India's largest and most recognisable companies, sitting at a market cap of nearly Rs 3.93 lakh crore and currently trading at Rs 305. Now, a lot of people hear ITC and immediately think cigarettes — and yes, tobacco is still the engine that runs this company. But there is a lot more going on here. Let's talk numbers first. The P/E ratio is 19, which for a company of this quality and size is genuinely reasonable — not cheap, not expensive. The ROCE, which tells us how efficiently the company uses its money, is a staggering 36.79%. To put that in perspective, very few large companies in India come close to that number. It basically means every rupee ITC puts to work generates exceptional returns. Profit growth this year is a very impressive 73%, though I'd urge some caution — part of that could be base effects or accounting adjustments from the hotels demerger. Sales growth at 8.4% is more modest, which reflects the reality that the core tobacco business isn't growing fast volumes. Now, here's what makes ITC special for many investors — the dividend. A 4.58% dividend yield is outstanding. That means if you put Rs 1 lakh in ITC today, you'd receive roughly Rs 4,580 every year just sitting back and doing nothing. For conservative investors or those planning for retirement, this is a real attraction. The risks? Tobacco regulations are tightening. ESG funds won't touch it. And the FMCG businesses, despite years of effort, are still finding their footing. My take — ITC is a BUY for patient, income-focused investors with a 2-year horizon. It won't make you rich overnight, but it will reward you steadily. Think of it as a reliable dividend compounder with a slow-burn growth story attached.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer